- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01365897
Effectiveness of Modafinil in Improving Cognitive Performance of University Students
June 2, 2011 updated by: Universidad de Valparaiso
Effectiveness of Modafinil in Improving Mnesic Performance and Executive Functions of University Students From Careers of High Academic Performance
The purpose of this study is to determine whether modafinil is effective in the improvement of mnesic performance and executive functions of university students from high academic performance.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
128
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
V Region
-
Valparaiso, V Region, Chile
- Escuela de Medicina, Universidad de Valparaíso
-
Valparaiso, V Region, Chile
- Escuela de Psicología, Universidad de Valparaiso
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 25 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Medicine, Psychology, Obstetrics, Nursing and Kinesiology students of the Universidad de Valparaiso.
Exclusion Criteria:
- Patients with Mental Disorders.
- Patients with physical diseases.
- Patients using any psychotropic substances.
- History of chronic diseases.
- Pregnant women.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Placebo
Control Group
|
Modafinil 200mg
Other Names:
|
Experimental: Modafinil 200mg
Modafinil 200mg taken orally.
|
Modafinil 200mg
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Average Correct Answers in Biber Cognitive Estimation Test
Time Frame: 2 hours after pill ingestion
|
2 hours after pill ingestion
|
Average response latency in Stroop Effect test
Time Frame: 2 hours after pill ingestion
|
2 hours after pill ingestion
|
Average Score in Digit Span test
Time Frame: 2 hours after pill ingestion
|
2 hours after pill ingestion
|
Average Score in Backwards Digit Span test
Time Frame: 2 hours after pill ingestion
|
2 hours after pill ingestion
|
Average percentage of correct answers in Stroop Effect test
Time Frame: 2 hours after pill ingestion
|
2 hours after pill ingestion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Alejandro Fernández, Psychologist, Universidad de Valparaiso
- Study Director: Eva Madrid, PhD, Universidad de Valparaiso
- Study Director: Andrés Painel, BM BCh, Universidad de Valparaiso
- Study Director: Jonathan Norambuena, BM BCh, Universidad de Valparaiso
- Study Director: Franco Mascayano, Psychologist, Universidad de Valparaiso
- Study Director: Walter Lips, Psychiatrist, Universidad de Valparaiso
- Study Director: Ortega Alonso, Psychologist, Universidad de Valparaiso
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (Actual)
January 1, 2011
Study Completion (Actual)
January 1, 2011
Study Registration Dates
First Submitted
May 31, 2011
First Submitted That Met QC Criteria
June 2, 2011
First Posted (Estimate)
June 3, 2011
Study Record Updates
Last Update Posted (Estimate)
June 3, 2011
Last Update Submitted That Met QC Criteria
June 2, 2011
Last Verified
November 1, 2010
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 04/2010
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Executive Function
-
University School of Physical Education in WroclawActive, not recruitingCognitive Function | Executive FunctionPoland
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Recruiting
-
University of North Carolina, Chapel HillSigma XiCompleted
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)CompletedExecutive FunctionUnited States
-
Universitaire Ziekenhuizen KU LeuvenUnited States Department of DefenseNot yet recruiting
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)CompletedExecutive FunctionUnited States
-
Rotman Research Institute at BaycrestUniversity of TorontoUnknown
-
University of Sao PauloSwiss Tropical & Public Health Institute; Grand Challenges Canada; Harvard University and other collaboratorsUnknown
-
National Taiwan University HospitalCompletedExecutive Function | NeurosciencesTaiwan
-
Tjhin WigunaDr Cipto Mangunkusumo General Hospital; Fakultas Kedokteran Universitas Indonesia and other collaboratorsCompleted
Clinical Trials on Modafinil
-
The Cooper Health SystemCompletedPostoperative Cognitive Dysfunction
-
Genuine Research Center, EgyptChemipharm Pharmaceutical Industries, EgyptCompleted
-
University of PennsylvaniaNational Institute on Drug Abuse (NIDA)Completed
-
SanofiCompletedBreast Cancer | Prostatic NeoplasmsAustralia
-
Jonsson Comprehensive Cancer CenterCephalonCompletedFatigue | Brain and Central Nervous System Tumors | Cognitive/Functional EffectsUnited States
-
VA Palo Alto Health Care SystemTerminatedInsomnia | Sleep Initiation and Maintenance Disorders | Alzheimer DiseaseUnited States
-
California Pacific Medical Center Research InstituteCompletedMethamphetamine AddictionUnited States
-
California Pacific Medical Center Research InstituteUnknownSubstance Dependence | Amphetamine DependenceUnited States
-
Cephalon, Inc.TerminatedObstructive Sleep Apnea | Narcolepsy | Shift Work Sleep DisorderUnited States